Marek Smieja

12.8k total citations · 2 hit papers
203 papers, 8.5k citations indexed

About

Marek Smieja is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Marek Smieja has authored 203 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Epidemiology, 71 papers in Infectious Diseases and 42 papers in Microbiology. Recurrent topics in Marek Smieja's work include Respiratory viral infections research (50 papers), Reproductive tract infections research (35 papers) and Pneumonia and Respiratory Infections (28 papers). Marek Smieja is often cited by papers focused on Respiratory viral infections research (50 papers), Reproductive tract infections research (35 papers) and Pneumonia and Respiratory Infections (28 papers). Marek Smieja collaborates with scholars based in Canada, United States and Botswana. Marek Smieja's co-authors include James B. Mahony, Mark Loeb, Max Chernesky, Fiona Smaill, Astrid Petrich, Lehana Thabane, Sylvia Chong, Kathy Luinstra, Catherine Marchetti and Lawrence Mbuagbaw and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Marek Smieja

196 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection

2018 773 citations Jeffrey C. Kwong, Kevin L. Schwartz et al. New England Journal of Medicine profile →
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection

2016 477 citations Marek Smieja et al. profile →

Peers

Countries citing papers authored by Marek Smieja

Since Specialization

Citations

This map shows the geographic impact of Marek Smieja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Smieja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Smieja more than expected).

Fields of papers citing papers by Marek Smieja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Smieja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Smieja. The network helps show where Marek Smieja may publish in the future.

Co-authorship network of co-authors of Marek Smieja

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Smieja. A scholar is included among the top collaborators of Marek Smieja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Smieja. Marek Smieja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017–2019 2025 ·The Journal of Infectious Diseases ·Sarah A. Buchan, (unknown), Samantha S. M. Drover, Melissa K. Andrew, Susan E. Bronskill, Kevin A. Brown, Nick Daneman, Shelley L. Deeks, Jonathan B. Gubbay, Jennie Johnstone, Timothy Karnauchow, Samantha Lee, (unknown), James Dayre McNally, Shelly McNeil, Samira Mubareka, Michelle Murti, Marek Smieja, (unknown), Jeffrey C. Kwong	0
2	Molecular Epidemiology of Clinical Infections Caused by Serratia marcescens Complex in a Tertiary Care Hospital System: Insights From Whole-Genome Sequencing 2025 ·The Journal of Infectious Diseases ·Adam S. Komorowski, Michael G. Surette, Laura Rossi, (unknown), (unknown), (unknown), Andrew G. McArthur, Marek Smieja, Dominik Mertz	0
3	Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccines 2024 ·Vaccine ·Brenda L. Coleman, Iris Gutmanis, Susan J. Bondy, (unknown), Joanne M. Langley, (unknown), Curtis Cooper, Louis Valiquette, Matthew Muller, Jeff Powis, Dawn M. E. Bowdish, Kevin Katz, Mark Loeb, Marek Smieja, Shelly McNeil, Samira Mubareka, Jeya Nadarajah, (unknown), Allison McGeer	4
4	Chronic COVID-19 infection in an immunosuppressed patient shows changes in lineage over time: a case report 2024 ·Virology Journal ·Sheridan J.C. Baker, (unknown), Daniela Leto, (unknown), Marek Smieja, Andrew G. McArthur	3
5	Evaluating the Impact of Statin Use on Influenza Vaccine Effectiveness and Influenza Infection in Older Adults 2023 ·Clinical Infectious Diseases ·Hannah Chung, Michael A. Campitelli, Sarah A. Buchan, Aaron Campigotto, Branson Chen, Natasha S. Crowcroft, Vinita Dubey, Jonathan B. Gubbay, Timothy Karnauchow, Kevin Katz, Allison McGeer, James Dayre McNally, Samira Mubareka, Michelle Murti, David Richardson, Laura C. Rosella, Kevin L. Schwartz, Marek Smieja, George Zahariadis, Jeffrey C. Kwong	4
6	Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review 2023 ·Clinical Infectious Diseases ·Carson K. L. Lo, Adam S. Komorowski, Clayton W. Hall, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Fiona Smaill, (unknown), Marek Smieja, Dominik Mertz, Anthony D. Bai	4
7	The impact of HIV co-infection on presentation and outcome in adults with tuberculous pericarditis: Findings from the IMPI trial 2023 ·South African Medical Journal ·Freedom Gumedze, Shaheen Pandie, (unknown), (unknown), Veronica Francis, Lehana Thabane, Marek Smieja, Jackie Bosch, Salim Yusuf, Mpiko Ntsekhe, Graeme Meintjes, Bongani M. Mayosi	2
8	COVID-19 international border surveillance at Toronto’s Pearson Airport: a cohort study 2021 ·BMJ Open ·Vivek Goel, David Bulir, (unknown), (unknown), Laura C. Rosella, Dominik Mertz, Cheryl Regehr, Marek Smieja	13
9	Paediatric critical illness associated with respiratory infection: a single-centre, retrospective cohort study 2020 ·BMJ Paediatrics Open ·(unknown), Kathy Luinstra, Alireza Eshaghi, Marek Smieja, Jonathan B. Gubbay, Jeffrey M. Pernica	2
10	Overview of systematic reviews on strategies to improve treatment initiation, adherence to antiretroviral therapy and retention in care for people living with HIV: part 1 2020 ·BMJ Open ·Lawrence Mbuagbaw, Anisa Hajizadeh, Annie Wang, Dominik Mertz, Daeria O. Lawson, Marek Smieja, Anita C. Benoit, Elizabeth Álvarez, (unknown), Beth Rachlis, Carmen H. Logie, Winston Husbands, Shari Margolese, Babalwa Zani, Lehana Thabane	23
11	Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort 2019 ·Vaccine ·Jeffrey C. Kwong, Sarah A. Buchan, Hannah Chung, Michael A. Campitelli, Kevin L. Schwartz, Natasha S. Crowcroft, Michael L. Jackson, Timothy Karnauchow, Kevin Katz, Allison McGeer, James Dayre McNally, David Richardson, Susan E. Richardson, Laura C. Rosella, Andrew E. Simor, Marek Smieja, George Zahariadis, Aaron Campigotto, Jonathan B. Gubbay	24
12	Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection breakdown → 2018 ·New England Journal of Medicine ·Jeffrey C. Kwong, Kevin L. Schwartz, Michael A. Campitelli, Hannah Chung, Natasha S. Crowcroft, Timothy Karnauchow, Kevin Katz, Dennis T. Ko, Allison McGeer, Dayre McNally, David Richardson, Laura C. Rosella, Andrew E. Simor, Marek Smieja, George Zahariadis, Jonathan B. Gubbay	773
13	Trends and Correlates of Cigarette Smoking and Its Impacts on Health-Related Quality of Life Among People Living with HIV: Findings from the Ontario HIV Treatment Network Cohort Study, 2008–2014 2017 ·AIDS Patient Care and STDs ·Tsegaye Bekele, Sergio Rueda, Sandra Gardner, Janet Raboud, Marek Smieja, Richard Kennedy, David Fletcher, Ann N. Burchell, Jean Bacon, Sean B. Rourke, (unknown)	22
14	Correlation of Clinical Outcomes With Multiplex Molecular Testing of Stool From Children Admitted to Hospital With Gastroenteritis in Botswana 2015 ·Journal of the Pediatric Infectious Diseases Society ·Jeffrey M. Pernica, Andrew P. Steenhoff, (unknown), Margaret Mokomane, Isaac K. Quaye, Tonya Arscott‐Mills, Loeto Mazhani, Kwana Lechiile, James B. Mahony, Marek Smieja, David A. Goldfarb	21
15	Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study 2015 ·Trials ·(unknown), (unknown), Joseph Beyene, Marek Smieja, Lehana Thabane	3
16	The Loss of Topography in the Microbial Communities of the Upper Respiratory Tract in the Elderly 2014 ·Annals of the American Thoracic Society ·Fiona Whelan, Chris P. Verschoor, Jennifer C. Stearns, Laura Rossi, Kathy Luinstra, Mark Loeb, Marek Smieja, Jennie Johnstone, Michael G. Surette, Dawn M. E. Bowdish	156
17	Mobile phone text messages for improving adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised trials 2013 ·BMJ Open ·Lawrence Mbuagbaw, Mia L. van der Kop, Richard Lester, Harsha Thirumurthy, Cristian Pop‐Eleches, Chenglin Ye, Marek Smieja, Lisa Dolovich, Edward J. Mills, Lehana Thabane	121
18	Safety and Tolerability of Varenicline Tartrate (Champix ^® /Chantix ^® ) for Smoking Cessation in HIV-Infected Subjects: A Pilot Open-Label Study 2011 ·AIDS Patient Care and STDs ·Qu Cui, Linda Robinson, Dawn Elston, Fiona Smaill, Jeffrey Cohen, (unknown), Nancy McFarland, Lehana Thabane, Andrew McIvor, Johannes Zeidler, Marek Smieja	56
19	A CD4+ Cell Count <200 Cells per Cubic Millimeter at 2 Years After Initiation of Combination Antiretroviral Therapy Is Associated With Increased Mortality in HIV-Infected Individuals With Viral Suppression 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mona Loutfy, Miguel Genebat, David J. Moore, Janet Raboud, Keith Chan, Tony Antoniou, David J. Milan, (unknown), Marina B. Klein, Curtis Cooper, Nimâ Machouf, Sean B. Rourke, Anita Rachlis, Chris Tsoukas, Julio Montaner, Sharon Walmsley, Marek Smieja, Ahmed M. Bayoumi, Edward J. Mills, Robert S. Hogg	39
20	Once Daily Dosing Improves Adherence to Antiretroviral Therapy 2010 ·AIDS and Behavior ·Janet Raboud, Maggie Li, Sharon Walmsley, Curtis Cooper, Sandra Blitz, Ahmed M. Bayoumi, Sean B. Rourke, Sergio Rueda, Anita Rachlis, Nicole Mittmann, Marek Smieja, Evan Collins, Mona Loutfy	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact